本页面由Tiger Trade Technology Pte. Ltd.提供服务

Homology Medicines Inc.

0.9347
0.0000
成交量:- -
成交额:37.64万
市值:5,433.74万
市盈率:-0.48
高:0.9347
开:0.9347
低:0.9347
收:0.9347
52周最高:1.76
52周最低:0.4580
股本:5,813.35万
流通股本:3,676.37万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.9532
每股收益(LYR):-1.9532
净资产收益率:-90.02%
总资产收益率:-36.40%
市净率:0.74
市盈率(LYR):-0.48

数据加载中...

2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

重要事件披露

8-K - Current report
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

重要事件披露

8-K - Current report
2020/12/18

重要事件披露

8-K - Current report
2020/11/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/21

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/01

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/20

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals